Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
8 drugs in development
By Therapeutic Area
top 5
R&D Momentum
92/100
Pipeline Velocity
69/100
Trial Completion Rate
73/100
Pipeline Concentration
18/100
Pipeline Freshness
69/100
Strategic Signals
Activity
Last 14 days
Target Validation of Interleukin-4 Receptor Alpha for Major Depressive Disorder
Abbreviated MRI for HCC Screening in Cirrhotic Patients (FAST-MRI Study)
Dissecting Neurocognitive Components of Compulsivity Using Computational Modeling and EEG
Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSD
The Coma Family Program (COMA-F): A Multi-site Clinical Trial of a Resilience Program for Caregivers of Patients With Severe Acute Brain Injury
Microtesla Magnetic Therapy (MMT) Treatment of Cognitive Impairment: Open Label Pilot Study
Extended Home-use Trial of a Novel Device to Reduce Chronic Pain
Use of Paired Non-Invasive Vagus Nerve Stimulation in Rehabilitation of Adolescents With Cerebral Palsy: An Open Label Safety Feasibility Trial
Healing Track Randomized Clinical Trial
SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction (SHIELD)
Chronic Subdural Hematoma Treated With Numen SILK Coiling of Middle Meningeal Artery
Comprehensive Phenotyping of Type 1 Gaucher Disease Patients for Prodromal Parkinson's Disease: A Behavioral and Biomarker Study
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)